IVF Costing in the US: Per Cycle, Per Round, Per Baby

You are sitting at a kitchen table or in a car after the financial consult. Someone handed you a quote. Fourteen thousand five hundred dollars for a fresh cycle. Plus meds. Plus PGT. Plus storage. Plus the FET. You did not understand half of it, and the half you did understand is not the number your friend two states over paid. You came here because IVF costing in the US is opaque on purpose, and you want to know if you are being quoted fairly.

I will give you the version of this conversation I have in clinic with patients, including the parts that financial counselors are too polite to say out loud. The numbers in this post reflect US pricing in 2024 to 2025 and will shift; we re-review them annually. The math will not.

Why IVF costing is the wrong question on its own

The real number is cost per live birth, not cost per cycle. They are different by a multiple.

The mean number of cycles to a live birth in the US is roughly 1.6 for patients under 35, climbing to about 2.5 for ages 38 to 40, and substantially higher above 40 with own eggs¹. That means the sticker-shock per-cycle number is a fraction of the take-home-baby number for most patients. The financial conversation that helps is the one that asks: at my age and diagnosis, what is the cumulative spend I should plan for, and what payment structures protect me on the downside?

The rest of this post separates the line items so you can ask better questions at your next financial consult.

The five things every quote should itemize

A "bundled" IVF quote can hide enormous variance. When you receive your written estimate, look for these five components broken out:

1. Clinic professional fee (covers monitoring, retrieval, and transfer): typically USD 12,000 to 18,000 in US pricing today.
2. Anesthesia and facility fee for retrieval: USD 800 to 2,500, sometimes bundled with the clinic fee, sometimes billed separately by an anesthesia group.
3. Medications (gonadotropins, antagonist, trigger, luteal support): USD 3,000 to 7,000 depending on dose. Higher in poor responders who need larger gonadotropin doses for longer.
4. ICSI, when used: USD 1,500 to 2,500 add-on. Standard for male factor and PGT cycles, optional for many others.
5. Add-ons (assisted hatching, embryo glue, EmbryoScope time-lapse, endometrial scratch): USD 200 to 1,500 each.

The add-ons deserve a separate sentence. Ask which add-ons have evidence for your case. Some have RCT support in specific subgroups. Some do not. A clinic that recommends every add-on for every patient is not practicing evidence-based medicine.

PGT-A: when it adds value and when it does not

PGT-A is USD 3,000 to 6,000 as a platform fee, plus USD 200 to 500 per embryo biopsied. Five blastocysts biopsied easily lands at USD 4,500 to 8,500 added to the cycle.

The cost-effectiveness debate is real. The STAR trial, a multicenter randomized controlled trial, showed no live-birth advantage of PGT-A versus morphology selection in the general IVF population². Where PGT-A may still help:

• Advanced maternal age (above 38), where aneuploidy rates rise sharply.
• Recurrent pregnancy loss with prior chromosomal abnormality.
• Multiple failed transfers of morphologically good embryos.
• Large embryo cohorts where you need to prioritize which to transfer first.

The question is not "is PGT-A worth it." The question is "is PGT-A worth it for me, at my age, with my embryo cohort." A good RE will give you the math.

FET costs and the freeze-all reality

Most cycles in 2024 to 2025 include a freeze-all at most US clinics, especially for PCOS, PGT, or high responders, in part to lower OHSS risk. So your "one cycle" is often two billing events:

• FET cycle (medications, monitoring, transfer): USD 3,000 to 6,000.
• Cryopreservation initial fee: USD 500 to 1,500.
• Annual storage fee: USD 500 to 1,000 per year, billed yearly until you discard or use.

Plan the FET cost into the original budget, not as a surprise add-on. Storage costs add up quietly if a cycle gets paused.

Total range: per cycle, per round

Putting the above together for US pricing in 2024 to 2025:

• Fresh single-transfer cycle, no PGT: USD 17,000 to 30,000 all-in (clinic + meds + anesthesia).
• Freeze-all + first FET, no PGT: USD 22,000 to 37,000.
• Freeze-all + PGT-A + first FET: USD 27,000 to 45,000.

For "cost per live birth," multiply by the cycles-to-baby number for your age band. A typical patient under 38 with good prognosis lands at roughly 1.6x to 2.5x these numbers by the time they reach a live birth. For some patients it is one cycle and done. For others it is three.

Donor egg, donor sperm, and gender selection

These are separate cost categories that come up often in search.

• Donor egg IVF cost in the US: typically USD 25,000 to 45,000 for the cycle including donor compensation, donor screening, and synchronization. Donor egg banks (frozen eggs) tend to run lower; fresh donor cycles run higher.
• Donor sperm: USD 700 to 1,500 per vial, plus shipping. Most cycles use one to three vials. If you are still weighing whether to try IUI before moving to IVF, the per-cycle gap is large.
• PGT-M for sex chromosome selection (for family balancing): the technical service is built on PGT-A infrastructure and typically adds USD 0 to 2,000 above standard PGT-A pricing. Note that gender selection for non-medical reasons is legal in the US but not all clinics offer it.

Insurance: the 22-state mandate map

As of 2024 to 2025, 22 US states have some form of fertility coverage mandate, tracked by RESOLVE³. Coverage varies enormously by state and by employer-size threshold:

• Some states mandate diagnostic-only coverage (your workup is paid, your treatment is not).
• Some mandate IUI coverage but not IVF.
• Some mandate IVF with a lifetime dollar cap (commonly USD 25,000 to 100,000).
• A few mandate true IVF coverage with limited or no caps.

The 2024 expansion of Federal Employee Health Benefits (FEHB) added IVF coverage for many federal employees, a significant change for that workforce. Employer-sponsored fertility benefits through vendors like Maven, Carrot, and Progyny are now offered by many large employers. Ask HR specifically about IVF coverage and lifetime caps, not just "fertility benefits."

Even when insurance covers IVF, most policies do not cover PGT-A. Read your benefits booklet. Then read it again.

I have seen patients drain retirement accounts. I have also seen patients who waited six months for a new job with a fertility benefit and paid USD 0. The financial path matters as much as the medical one, sometimes more. If you are within striking distance of a state mandate kicking in or a job change with benefits, do the calendar math before the financial one.

Financing and outcome-guarantee programs

• Multi-cycle / shared-risk / refund programs: pay USD 25,000 to 45,000 up front for two to three cycles, with partial or full refund if no live birth. The math favors patients under 35 with good prognosis because the program is taking risk against good odds. Patients with poor prognosis are often priced out of these programs intentionally.
• IVF loans: typical APR is 8 to 15 percent, depending on credit. Specialty fertility lenders (Future Family, Lightstream, ReproTech) compete with bank personal loans. Run the numbers.
• HSA and FSA dollars are eligible for IVF expenses. That converts to 20 to 30 percent pre-tax savings depending on your bracket. Most patients underuse this.
• Pharmacy savings: GoodRx, EMD Serono Compassionate Corps, Ferring patient assistance programs, and manufacturer savings cards can drop medication costs by 20 to 50 percent. The savings programs require an application; do it before the meds ship, not after.

Hidden costs people forget

These do not appear on the clinic quote:

• Lost work hours: five to eight morning monitoring visits over two weeks, plus retrieval day and transfer day. For salaried patients this may be invisible. For hourly patients it is direct lost income.
• Travel: monitoring at a specialty clinic, banking cycles at a tertiary center, donor cycles requiring travel.
• Embryo storage running cost: billed annually and easy to forget.
• Mental health support: therapy specific to fertility is rarely fully covered by insurance.
• Genetic counseling for PGT-M cases.
• Acupuncture, supplements, naturopathic protocols: out of pocket, often substantial, with mixed evidence⁴.

What to ask before signing the financial consent

This is the list I would bring into the financial counselor's office:

• Is the quoted fee a bundle or itemized? What is bundled in and what is extra?
• Does the clinic charge per monitoring visit or by package?
• Is the embryology lab fee separate from the retrieval fee?
• Does anesthesia bill separately, and through whom?
• What is the FET fee from a frozen cohort, and does it include lining-prep medications?
• Is freeze-all included if my cycle converts, or does it incur a new charge?
• Do you offer a multi-cycle or shared-risk program, and what is the math for someone in my age band and diagnosis?
• If my cycle is cancelled at baseline or during stim, what is refunded and what is forfeited?
• Are payment plans available, and what is the interest rate?

Bring a notepad. Write the answers in dollars. Compare across two or three clinics if you have the option.

What you can do this week

Practical steps that move IVF costing from opaque to itemised:

• Request an itemized estimate in writing from your clinic. If they only provide a bundle, ask for the line-item breakdown.
• Check the RESOLVE state mandate tracker for your state, even if you think you know your coverage.
• Call HR or your benefits portal and ask specifically: "Is IVF covered? What is the lifetime cap? Is PGT covered? Is medication covered?"
• Pull your HSA or FSA contribution and increase contributions before open enrollment if you can. The pre-tax savings are real.
• Apply for manufacturer savings programs for the specific medications named on your protocol sheet. They take a week to ten days to process.

What's next

• If you want to map the dollars onto the calendar, read how long an IVF cycle takes.
• If you want to understand the cumulative-cycle math that drives the per-live-birth number, read IVF success rates: honest numbers by age and diagnosis.
• If you are weighing whether PGT-A is worth the spend in your case, read PGT-A, M, and SR explained.
• If you have PCOS and the cost of a freeze-all-by-default cycle is part of the picture, read IVF with PCOS.

Related in this cluster

• IVF Step by Step: The Full Process Timeline

Sources

1. Society for Assisted Reproductive Technology (SART). National Summary Report (CORS), preliminary data on cumulative cycles to live birth. https://www.sartcorsonline.com/
2. Munné S, Kaplan B, Frattarelli JL, et al. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertility and Sterility 2019;112(6):1071-1079.e7. https://doi.org/10.1016/j.fertnstert.2019.07.1346
3. RESOLVE: The National Infertility Association. Insurance Coverage by State. https://resolve.org/get-help/insurance-coverage/
4. Katz P, Showstack J, Smith JF, et al. Costs of infertility treatment: results from an 18-month prospective cohort study. Fertility and Sterility 2011;95(3):915-921. https://doi.org/10.1016/j.fertnstert.2010.11.026
5. Chambers GM, Adamson GD, Eijkemans MJ. Acceptable cost for the patient and society. Fertility and Sterility 2013;100(2):319-327. https://doi.org/10.1016/j.fertnstert.2013.06.017
6. Centers for Disease Control and Prevention (CDC). Assisted Reproductive Technology National Summary Report. https://www.cdc.gov/art/index.html